About Us
Newsletter / Events
Contact Us
Case Western Reserve University
Case Department of Neurology
Alzheimer Association
Integrative Studies
Laboratory of Neurogeriatrics
Alzheimer Research Centers

Clinical Drug Studies

What is a Clinical Drug Study?

A clinical trial is also called a clinical drug study, is research that enables physicians and scientists to determine the safety and effectiveness of new drugs or treatments. The Food and Drug Administration sets strict guidelines and regulations for clinical drug studies, and sponsoring pharmaceutical companies, hospitals, and academic institutions also require that studies be carried out precisely as planned.The Clinical drug study team at UMAC includes physicians, nurses, psychologists and coordinators who work together to make your clinical trial experience safe, informative, and meaningful.

Participating in a Clinical Drug Study

Before entering a clinical drug study, it is the responsibility of the Center staff to make sure you meet the eligibility requirements, and to let you know what the study will involve. This is accomplished by thoroughly discussing the study and answering any questions you may have.

At that point, if you agree to participate, you will be asked to sign an informed consent, which documents the fact that you have chosen to be in the study, after proper review of any information related to your participation in the study.

Even though you have signed the informed consent,your participation is completely voluntary, and you may leave a study at any time you feel is necessary.


While everyone has the potential to participate in a clinical drug study, each trial has specific criteria for participation. Eligibility requirements are set by the sponsoring pharmaceutical company and/or the Federal government, and consequently, we have no flexibility in altering eligibility requirements. If you are not eligible for a current study, there may be an appropriate study for your consideration soon.

Current Clinical Drug Studies enrolling at our center

Valproate - A drug aiming to reduce challenging behaviors in people with Alzheimer's disease

Antioxidant Treatment of Alzheimer's disease A study of antioxidants on markers of Alzheimer's disease and aging.
Seguros medicamentos como sin receta del médico .

Alzheimer's Disease Neuroimaging Initiative (ADNI) - To predict and monitor the onset and progression of Alzheimer's disease [no research medication involved]; Individuals without memory problems are eligible

A full list of clinical trials throughout the country(enrolling and in progress) is available at www.clinicaltrials.gov

If you have any questions regarding these studies, please call Elaine Ziol at 216-844-6328 or email at elaine.ziol@case.edu

Benefits of Clinical Drug Studies

  • Access to new treatments
  • Regular contact with medical experts at the University Memory and Aging Center
  • Opportunities to contribute to advancements in treatment for Alzheimer's disease now and for future generations